T R Patel1,2, S Fricano1,3, M Waqas1,4, M Tso1,4, A A Dmytriw5, M Mokin6, J Kolega1,3, J Tomaszewski1,3, E I Levy1,4, J M Davies1,4,7, K V Snyder1,4, A H Siddiqui1,4, V M Tutino8,2,3,4,9. 1. From the Canon Stroke and Vascular Research Center (T.R.P., S.F., M.W., M.T., J.K., J.T., E.I.L., J.M.D., K.V.S., A.H.S., V.M.T.). 2. Department of Mechanical and Aerospace Engineering (T.R.P., V.M.T.). 3. Pathology and Anatomical Sciences (S.F., J.K., J.T., V.M.T.). 4. Neurosurgery (M.W., M.T., E.I.L., J.M.D., K.V.S., A.H.S., V.M.T.). 5. Department of Medical Imaging (A.A.D.), University of Toronto, Toronto, Ontario, Canada. 6. Department of Neurosurgery (M.M.), University of South Florida, Tampa, Florida. 7. Biomedical Informatics (J.M.D.), University at Buffalo, Buffalo, New York. 8. From the Canon Stroke and Vascular Research Center (T.R.P., S.F., M.W., M.T., J.K., J.T., E.I.L., J.M.D., K.V.S., A.H.S., V.M.T.) vincentt@buffalo.edu. 9. Biomedical Engineering (V.M.T.).
Abstract
BACKGROUND AND PURPOSE: Clot perviousness in acute ischemic stroke is a potential CT imaging biomarker for mechanical thrombectomy efficacy. We investigated the association among perviousness, clot cellular composition, and first-pass effect. MATERIALS AND METHODS: In 40 mechanical thrombectomy-treated cases of acute ischemic stroke, we calculated perviousness as the difference in clot density on CT angiography and noncontrast CT. We assessed the proportion of fibrin/platelet aggregates, red blood cells, and white blood cells on clot histopathology. We tested for linear correlation between histologic components and perviousness, differences in components between "high" and "low" pervious clots defined by median perviousness, and differences in perviousness/composition between cases that did and did not achieve a first-pass effect. RESULTS: Perviousness significantly positively and negatively correlated with the percentage of fibrin/platelet aggregates (P = .001) and the percentage of red blood cells (P = .001), respectively. Higher pervious clots had significantly greater fibrin/platelet aggregate content (P = .042). Cases that achieved a first-pass effect (n = 14) had lower perviousness, though not significantly (P = .055). The percentage of red blood cells was significantly higher (P = .028) and the percentage of fibrin/platelet aggregates was significantly lower (P = .016) in cases with a first-pass effect. There was no association between clot density on NCCT and clot composition or first-pass effect. Receiver operating characteristic analysis indicated that clot composition was the best predictor of first-pass effect (area under receiver operating characteristic curve: percentage of fibrin/platelet aggregates = 0.731, percentage of red blood cells = 0.706, perviousness = 0.668). CONCLUSIONS: Clot perviousness on CT is associated with a higher percentage of fibrin/platelet aggregate content. Histologic data and, to a lesser degree, perviousness may have value in predicting first-pass outcome. Imaging metrics that more strongly reflect clot biology than perviousness may be needed to predict a first-pass effect with high accuracy.
BACKGROUND AND PURPOSE: Clot perviousness in acute ischemic stroke is a potential CT imaging biomarker for mechanical thrombectomy efficacy. We investigated the association among perviousness, clot cellular composition, and first-pass effect. MATERIALS AND METHODS: In 40 mechanical thrombectomy-treated cases of acute ischemic stroke, we calculated perviousness as the difference in clot density on CT angiography and noncontrast CT. We assessed the proportion of fibrin/platelet aggregates, red blood cells, and white blood cells on clot histopathology. We tested for linear correlation between histologic components and perviousness, differences in components between "high" and "low" pervious clots defined by median perviousness, and differences in perviousness/composition between cases that did and did not achieve a first-pass effect. RESULTS: Perviousness significantly positively and negatively correlated with the percentage of fibrin/platelet aggregates (P = .001) and the percentage of red blood cells (P = .001), respectively. Higher pervious clots had significantly greater fibrin/platelet aggregate content (P = .042). Cases that achieved a first-pass effect (n = 14) had lower perviousness, though not significantly (P = .055). The percentage of red blood cells was significantly higher (P = .028) and the percentage of fibrin/platelet aggregates was significantly lower (P = .016) in cases with a first-pass effect. There was no association between clot density on NCCT and clot composition or first-pass effect. Receiver operating characteristic analysis indicated that clot composition was the best predictor of first-pass effect (area under receiver operating characteristic curve: percentage of fibrin/platelet aggregates = 0.731, percentage of red blood cells = 0.706, perviousness = 0.668). CONCLUSIONS: Clot perviousness on CT is associated with a higher percentage of fibrin/platelet aggregate content. Histologic data and, to a lesser degree, perviousness may have value in predicting first-pass outcome. Imaging metrics that more strongly reflect clot biology than perviousness may be needed to predict a first-pass effect with high accuracy.
Authors: John Charles Benson; Sean T Fitzgerald; Ramanathan Kadirvel; Collin Johnson; Daying Dai; Doyle Karen; David F Kallmes; Waleed Brinjikji Journal: J Neurointerv Surg Date: 2019-06-25 Impact factor: 5.836
Authors: W Qiu; H Kuang; J Nair; Z Assis; M Najm; C McDougall; B McDougall; K Chung; A T Wilson; M Goyal; M D Hill; A M Demchuk; B K Menon Journal: AJNR Am J Neuroradiol Date: 2018-12-20 Impact factor: 3.825
Authors: Peter B Sporns; Uta Hanning; Wolfram Schwindt; Aglae Velasco; Boris Buerke; Christian Cnyrim; Jens Minnerup; Walter Heindel; Astrid Jeibmann; Thomas Niederstadt Journal: Cerebrovasc Dis Date: 2017-10-31 Impact factor: 2.762
Authors: Bruna G Dutra; Manon L Tolhuisen; Heitor C B R Alves; Kilian M Treurniet; Manon Kappelhof; Albert J Yoo; Ivo G H Jansen; Diederik W J Dippel; Wim H van Zwam; Robert J van Oostenbrugge; Antônio J da Rocha; Hester F Lingsma; Aad van der Lugt; Yvo B W E M Roos; Henk A Marquering; Charles B L M Majoie Journal: Stroke Date: 2019-06-20 Impact factor: 7.914
Authors: Mark M McDonald; Joancy M Archeval-Lao; Chunyan Cai; Hui Peng; Navdeep Sangha; Stephanie A Parker; Jeremy Wetzel; Stephen A Riney; Matt F Cherches; Greer J Guthrie; Tiffany C Roper; Jorge F Kawano-Castillo; Renga Pandurengan; Mohammad H Rahbar; James C Grotta Journal: Stroke Date: 2013-12-26 Impact factor: 7.914
Authors: Gabriel Hertig; Matthias Zehnder; Anna Woloszyk; Thimios A Mitsiadis; Anja Ivica; Franz E Weber Journal: Front Physiol Date: 2017-03-15 Impact factor: 4.566
Authors: Emilie M M Santos; Albert J Yoo; Ludo F Beenen; Olvert A Berkhemer; Mark D den Blanken; Carrie Wismans; Wiro J Niessen; Charles B Majoie; Henk A Marquering Journal: Neuroradiology Date: 2015-10-22 Impact factor: 2.804
Authors: S Mostafa Mousavi J S; Danial Faghihi; Kelsey Sommer; Mohammad M S Bhurwani; Tatsat R Patel; Briana Santo; Muhammad Waqas; Ciprian Ionita; Elad I Levy; Adnan H Siddiqui; Vincent M Tutino Journal: J R Soc Interface Date: 2021-12-15 Impact factor: 4.118
Authors: Nerea Arrarte Terreros; Bettine G van Willigen; Wera S Niekolaas; Manon L Tolhuisen; Josje Brouwer; Jonathan M Coutinho; Ludo Fm Beenen; Charles Blm Majoie; Ed van Bavel; Henk A Marquering Journal: J Cereb Blood Flow Metab Date: 2021-09-22 Impact factor: 6.960
Authors: Vincent M Tutino; Sarah Fricano; Kirsten Frauens; Tatsat R Patel; Andre Monteiro; Hamid H Rai; Muhammad Waqas; Lee Chaves; Kerry E Poppenberg; Adnan H Siddiqui Journal: Genes (Basel) Date: 2021-10-14 Impact factor: 4.141